Craig-Hallum Maintains Buy on CareDx, Raises Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Connor Chamberlain has maintained a Buy rating on CareDx (NASDAQ:CDNA) and raised the price target from $22 to $32.
August 01, 2024 | 4:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Craig-Hallum analyst Connor Chamberlain has maintained a Buy rating on CareDx and raised the price target from $22 to $32.
The raised price target from $22 to $32 by a reputable analyst suggests increased confidence in CareDx's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100